UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mode of action of the new selective leukotriene synthesis inhibitor BAY X 1005 {( R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid} and structurally related compounds

Biochemical pharmacology, 1993, Vol.45 (1), p.101-111

1993

Volltextzugriff (PDF)

BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics

The Journal of pharmacology and experimental therapeutics, 1993-10, Vol.267 (1), p.51

1993

Volltextzugriff (PDF)

Inversely-correlated inhibition of human 5-lipoxygenase activity by bay X1005 and other quinoline derivatives in intact cells and a cell-free system—implications for the function of 5-lipoxygenase activating protein

Biochemical pharmacology, 1994-06, Vol.47 (12), p.2259-2268

1994

Volltextzugriff (PDF)

Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4

Biochemical pharmacology, 1994-07, Vol.48 (1), p.31-39

1994

Volltextzugriff (PDF)

In vitro pharmacology of BAY X1005, a new inhibitor of leukotriene synthesis

Agents and Actions, 1993-03, Vol.38 (3-4), p.188-195

1993

Volltextzugriff (PDF)

Leukotriene Synthesis Inhibitors of the Quinoline Type: Parameters for the Optimization of Efficacy

European journal of medicinal chemistry, 1995, Vol.30, p.441s-451s

1995

Volltextzugriff (PDF)

Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X 1005: implications for biological regulation of 5-lipoxygenase

Agents and Actions, 1994-11, Vol.43 (1-2), p.64-68

1994

Volltextzugriff (PDF)

The antipsoriatic drug, anthralin, inhibits protein kinase C : implications for its mechanism of action

Archives of Dermatological Research, 1992-06, Vol.284 (3), p.179-183

1992

Volltextzugriff (PDF)

Mode of action of the new selective leukotriene synthesis inhibitor BAY X 1005 ((R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid) and structurally related compounds

Biochemical pharmacology, 1993-01, Vol.45 (1), p.101-111

1993

Volltextzugriff (PDF)

Effects of tiflucarbine as a dual protein kinase C/calmodulin antagonist on proliferation of human keratinocytes and release of reactive oxygen species from human leukocytes

Archives of Dermatological Research, 1991-01, Vol.283 (7), p.456-460

1991

Volltextzugriff (PDF)

Role of 5-lipoxygenase-activating protein in the regulation of 5-lipoxygenase activity in human neutrophils

Agents and Actions, 1994-08, Vol.41 (S2), p.C166-C168

1994

Volltextzugriff (PDF)

Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X1005. Implications for biological regulation of 5-lipoxygenase

Advances in prostaglandin, thromboxane, and leukotriene research, 1994, Vol.22, p.23

1994

Volltextzugriff (PDF)

Hemmung des Lipoxygenase- und Cyclooxygenaseweges im Arachidonsäure-Metabolismus durch Etofenamat

Aktuelle Rheumatologie, 1984-09, Vol.9 (5), p.165-168

1984

Volltextzugriff (PDF)

Ca 2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B 4

Biochemical pharmacology, 1994, Vol.48 (1), p.31-39

1994

Volltextzugriff (PDF)

Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largerly mediated by endogenously formed leukotriene B4

Biochemical pharmacology, 1994, Vol.48 (1), p.31-39

1994

Volltextzugriff (PDF)

Design, synthesis, and 5-lipoxygenase-inhibiting properties of 1-thio-substituted butadienes

Journal of medicinal chemistry, 1990-04, Vol.33 (4), p.1163-1170

1990

Volltextzugriff (PDF)

Acylated tripeptides as chemotaxin antagonists (author's transl)

Hoppe-Seyler's Zeitschrift für Physiologische Chemie, 1981-08, Vol.362 (8), p.1037

1981

Volltextzugriff (PDF)

Hemmung des Lipoxygenase- und Cyclooxygenaseweges im Arachidonsäure-Metabolismus durch Etofenamat

Aktuelle Rheumatologie, 1984-09, Vol.9 (5), p.165-168

1984

Volltextzugriff (PDF)

Characterization of T- and B-lymphocytes in cattle

Zentralblatt für Veterinärmedizin. Reihe B, 1977-06, Vol.24 (6), p.486

1977

Volltextzugriff (PDF)

Effects of tiflucarbine as a dual protein kinase C/calmodulin antagonist on proliferation of human kertinocytes and release of reactive oxygen species from human leukocytes

Archives of dermatological research (Print), 1991, Vol.283 (7), p.456-460

1991

Volltextzugriff (PDF)

Synthetic tripeptides as chemotaxins or chemotaxin antagonists (author's transl)

Hoppe-Seyler's Zeitschrift für Physiologische Chemie, 1981-02, Vol.362 (2), p.163

1981

Volltextzugriff (PDF)

ChemInform Abstract: Design, Synthesis, and 5‐Lipoxygenase‐Inhibiting Properties of 1‐Thio‐Substituted Butadienes

ChemInform, 1990-11, Vol.21 (48), p.no-no

1990

Volltextzugriff (PDF)

Zur Charakterisierung von T- und B-Lymphozyten beim Rind

Zentralblatt für Veterinärmedizin Reihe B, 1977-08, Vol.24 (6), p.486-496

1977

Volltextzugriff (PDF)

BAY X1005, a new selective inhibitor of leukotriene synthesis: pharmacology and pharmacokinetics

Journal of lipid mediators, 1993-03, Vol.6 (1-3), p.245

1993

Volltextzugriff (PDF)

Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis

Netherlands journal of medicine, 1999-02, Vol.54 (2), p.46-62

1999

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(25)

Sprache

Englisch
(20)
Deutsch
(5)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Mode of action of the new selective leukotriene synthesis inhibitor BAY X 1005 {( R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid} and structurally related compounds

BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics

Inversely-correlated inhibition of human 5-lipoxygenase activity by bay X1005 and other quinoline derivatives in intact cells and a cell-free system—implications for the function of 5-lipoxygenase activating protein

Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4

In vitro pharmacology of BAY X1005, a new inhibitor of leukotriene synthesis

Leukotriene Synthesis Inhibitors of the Quinoline Type: Parameters for the Optimization of Efficacy

Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X 1005: implications for biological regulation of 5-lipoxygenase

The antipsoriatic drug, anthralin, inhibits protein kinase C : implications for its mechanism of action

Mode of action of the new selective leukotriene synthesis inhibitor BAY X 1005 ((R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid) and structurally related compounds

Effects of tiflucarbine as a dual protein kinase C/calmodulin antagonist on proliferation of human keratinocytes and release of reactive oxygen species from human leukocytes

Role of 5-lipoxygenase-activating protein in the regulation of 5-lipoxygenase activity in human neutrophils

Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X1005. Implications for biological regulation of 5-lipoxygenase

Hemmung des Lipoxygenase- und Cyclooxygenaseweges im Arachidonsäure-Metabolismus durch Etofenamat

Ca 2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B 4

Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largerly mediated by endogenously formed leukotriene B4

Design, synthesis, and 5-lipoxygenase-inhibiting properties of 1-thio-substituted butadienes

Acylated tripeptides as chemotaxin antagonists (author's transl)

Hemmung des Lipoxygenase- und Cyclooxygenaseweges im Arachidonsäure-Metabolismus durch Etofenamat

Characterization of T- and B-lymphocytes in cattle

Effects of tiflucarbine as a dual protein kinase C/calmodulin antagonist on proliferation of human kertinocytes and release of reactive oxygen species from human leukocytes

Synthetic tripeptides as chemotaxins or chemotaxin antagonists (author's transl)

ChemInform Abstract: Design, Synthesis, and 5‐Lipoxygenase‐Inhibiting Properties of 1‐Thio‐Substituted Butadienes

Zur Charakterisierung von T- und B-Lymphozyten beim Rind

BAY X1005, a new selective inhibitor of leukotriene synthesis: pharmacology and pharmacokinetics

Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis

Suchergebnisse filtern